Navigation Links
Late treatment with letrozole can reduce breast cancer recurrence risk
Date:3/10/2008

Treatment with the aromatase inhibitor letrozole (Femara) can reduce the risk of breast cancer recurrence even when initiated one to seven years after a course of tamoxifen therapy. The results of a study involving women originally in the placebo arm of an international trial of letrozole will appear in the Journal of Clinical Oncology and are receiving early online release. Among those who chose to begin letrozole treatment after the initial trial was halted, the risk that their cancer would recur was cut in half compared with those who never received letrozole. In addition, the risk of metastasis was 60 percent lower with letrozole, and the chance that a new tumor would develop in the unaffected breast dropped more than 80 percent.

It appears that estrogen-sensitive tumors remain hormone dependent and that patients survival can be improved with careful use of aromatase inhibitors, even many years after completing tamoxifen treatment, says Paul E. Goss, MD, PhD, director of Breast Cancer Research at Massachusetts General Hospital Cancer Center, who led both the current study and the earlier investigation, called the MA.17 trial. These results can be put into practice right away to improve the outlook for women treated for receptor-positive breast cancer.

Letrozole is one of a class of drugs called aromatase inhibitors that suppress the production of estrogen, which stimulates the growth of breast tumors expressing the estrogen receptor. The most widely used estrogen-blocking drug is tamoxifen, but the benefits of tamoxifen treatment drop significantly after five years, while the drugs side effects continue.

The original MA.17 trial, conducted through the National Cancer Institute of Canada, was designed to test whether letrozole could reduce tumor recurrence and increase survival in breast cancer patients who had completed five years of tamoxifen treatment. The study was halted in October 2003 a year earlier than planned whe
'/>"/>

Contact: Stacy Neale
sneale@partners.org
617-643-3907
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cardiac effects associated with breast cancer treatment appear lower with dose-dense chemotherapy
2. Gender Bias at Play in Treatment of Knee Osteoarthritis
3. Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
4. Make or break time for osteoporosis treatment
5. Treatment for mild asthma leads to improved lung function
6. Emergency on-field treatment for neck injuries in young sports athletes no different than adults
7. Study Reveals Emergency On-Field Treatment for Neck Injuries in Young Collision Sports Athletes No Different Than Adults
8. In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market
9. New findings about the brain lead to treatment for eating disturbances
10. Arizona Senate Pushes for Smoking Cessation Treatments for State Medicaid Beneficiaries
11. DFW Partnership for Peak Health Care Performance Selects Data Aggregator for Diabetes Treatment Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 According to ... to Rethink the Use of Botox,” Botox injections ... since their approval in 2002 (Go to goo.gl/8iYbD). Although it ... quite popular with men. The injection makes facial wrinkles less ... Botox injection last for about three months. This means that ...
(Date:5/21/2013)... May 21, 2013 Global Proving Ground ... Bodybuilding.com, the largest online retailer of health and fitness ... reality-based sports show, Warrior Island. “We cast the ... Facebook & Twitter, with our unique social networking platform,” ... these elite fighters on an island in the Pacific ...
(Date:5/21/2013)... into genetic features of pulmonary fibrosis by physicians and ... may lead to improved treatment of this deadly lung ... JAMA . , The study found that a particular ... pulmonary fibrosis, a chronic progressive disease with a median ... study, researchers may want to consider including genetic testing ...
(Date:5/21/2013)... 21, 2013 The Las Vegas personal injury ... announce that Crawford Gates, a senior at Coronado High School, ... scholarship essay contest . As the winner of the essay ... contest started on Dec. 1, 2012 and ran through April ... submit a three-page minimum essay on “The Role of the ...
(Date:5/21/2013)... While North Carolina is synonymous with ... guides. Brunswick Plantation & Golf Resort is synonymous with ... to 27 holes of "Top10" championship golf. , ... knowing the Top 10 from an industry ... overwhelming task of selecting the course to play. Guests ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
... Oct. 17 ,PainCare Holdings, Inc. (Amex: ... providers,of pain-focused medical and surgical solutions and ... MDFI), a company specializing in,portable electronic medical ... of a partnership created to market the ...
... Help Pave the Way Toward Malaria ... Eradication U.S. Presidential Candidates Urged to Sustain and Expand ... Malaria Initiative, ... audacious goal - to reach a,day when no human being has malaria, and no mosquito ...
... Well Life Center in Mesa,Arizona, a leader in adult ... its "10 Healing Secrets to Health,& Longevity Workshop" on ... This session will teach you principals to achieve longevity ... tips on how to set,health goals that are inline ...
... Oct. 17 In its Statement on Risk ... Oncologists (SGO) provides concise guidelines, usable in a,primary ... women with a personal,or family history of breast, ... risk assessment. SGO,s Statement on Risk Assessment ...
... 17 Laser Energetics,Inc. (Pink Sheets: LNGT) announced ... BrightStar solid-state Alexandrite lasers, for a non-lethal laser,defense ... The BrightStar(TM) laser is part of the Company,s ... BrightStar(TM) laser was purchased,for experiments that are classified, ...
... be published in the October edition of Hypertension Research ... bark of the French maritime pine tree, helps individuals ... to an increase in blood flow and oxygen supply ... produced by the body, increases blood flow that serves ...
Cached Medicine News:Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 4Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 5Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 6Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 2Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 3Health News:Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer 2Health News:Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer 3Health News:Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company 2Health News:New study: pine bark extract boosts nitric oxide production 2Health News:New study: pine bark extract boosts nitric oxide production 3
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... May 21, 2013  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include Actavis, Inc.,s (NYSE: ... SA (NYSE: TOT ), Petrobras (NYSE: PBR ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) ...
(Date:5/21/2013)... -- IsoRay, Inc. (AMEX: ISR ), ( http://www.isoray.com/ ... exclusive international distribution agreement with IASIS Medical for the ... Greece . IsoRay is a medical technology company ... for brain cancer, lung cancer, head and neck cancer, ... IASIS Medical is ideally suited to support IsoRay,s products, ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Stylet tube, endotracheal, sterile, stainless steel, malleable, one size, overall length 13"(33cm)....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Medicine Products: